Slingshot members are tracking this event:
Lilly to Present Data from Phase 3 Studies on Ixekizumab in Psoriasis and Psoriatic Arthritis
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Apr 07, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Phase 3 Data, Ixekizumab, Psoriasis, Psoriatic Arthritis